AAAAAA

   
Results: 1-10 |
Results: 10
ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME FOLLOWING KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION IN TYPE-I DIABETICS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME FOLLOWING KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION IN TYPE-I DIABETICS, Clinical transplantation, 12(2), 1998, pp. 93-98
THE EFFECTIVENESS OF A TRANSPLANT OUTPATIENT UNIT AS A COST-REDUCING STRATEGY FOLLOWING PANCREAS TRANSPLANTATION
Authors: DOUZDJIAN V LANZA KT UBER L SCHOLZ K RAJAGOPALAN PR
Citation: V. Douzdjian et al., THE EFFECTIVENESS OF A TRANSPLANT OUTPATIENT UNIT AS A COST-REDUCING STRATEGY FOLLOWING PANCREAS TRANSPLANTATION, Transplantation proceedings, 30(2), 1998, pp. 272-272
RISK-FACTORS FOR CLINICAL FAILURE FOLLOWING STATISTICALLY SUCCESSFUL KIDNEY-TRANSPLANTS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., RISK-FACTORS FOR CLINICAL FAILURE FOLLOWING STATISTICALLY SUCCESSFUL KIDNEY-TRANSPLANTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3167-3167
WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM LESS-THAN OPTIMAL DONORS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM LESS-THAN OPTIMAL DONORS, Journal of the American Society of Nephrology, 8, 1997, pp. 3169-3169
COMPARISON OF 2 ANTIMICROBIAL PROPHYLAXIS REGIMENS AFTER KIDNEY-PANCREAS TRANSPLANTS
Authors: BAILLIE GM DOUZDJIAN V SCHOLZ K UBER L BUNKE CM RAJAGOPALAN PR
Citation: Gm. Baillie et al., COMPARISON OF 2 ANTIMICROBIAL PROPHYLAXIS REGIMENS AFTER KIDNEY-PANCREAS TRANSPLANTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3298-3298
IMACT OF TREATMENT WITH NEORAL VERSUS SANDIMUNE ON OUTCOME VARIABLES IN LIVER-TRANSPLANT RECIPIENTS
Authors: BAILLIE GM BALIGA PK DOUZDJIAN V REUBEN A STOCKDELL R UBER L SINDHI R RAJAGOPALAN PR
Citation: Gm. Baillie et al., IMACT OF TREATMENT WITH NEORAL VERSUS SANDIMUNE ON OUTCOME VARIABLES IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 26(4), 1997, pp. 433-433
PROSTAGLANDIN E(1) ADMINISTRATION FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION - A RANDOMIZED PROSPECTIVE MULTICENTER TRIAL
Authors: KLEIN AS COFER JB PRUETT TL THULUVATH PJ MCGORY R UBER L STEVENSON WC BALIGA P BURDICK JF
Citation: As. Klein et al., PROSTAGLANDIN E(1) ADMINISTRATION FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION - A RANDOMIZED PROSPECTIVE MULTICENTER TRIAL, Gastroenterology, 111(3), 1996, pp. 710-715
THE EFFECTS OF PROSTAGLANDIN-E1 ON HEPATIC ALLOGRAFT VASCULAR INFLOW - A PROSPECTIVE RANDOMIZED DOUBLE-BLIND-STUDY
Authors: CHAVIN KD UBER L BALIGA P RAJAGOPALAN P COFER JB
Citation: Kd. Chavin et al., THE EFFECTS OF PROSTAGLANDIN-E1 ON HEPATIC ALLOGRAFT VASCULAR INFLOW - A PROSPECTIVE RANDOMIZED DOUBLE-BLIND-STUDY, The American surgeon, 62(3), 1996, pp. 184-187
EFFECTIVENESS OF COMBINATION PROPHYLAXIS WITH CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN AND ACYCLOVIR IN THE HIGH-RISK KIDNEY-TRANSPLANT RECIPIENT
Authors: UBER L COFER J BALIGA P RAJAGOPALAN PR
Citation: L. Uber et al., EFFECTIVENESS OF COMBINATION PROPHYLAXIS WITH CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN AND ACYCLOVIR IN THE HIGH-RISK KIDNEY-TRANSPLANT RECIPIENT, Transplantation proceedings, 27(5), 1995, pp. 42-43
IMMUNOSUPPRESSIVE MEDICINES
Authors: DUFFY MM UBER L
Citation: Mm. Duffy et L. Uber, IMMUNOSUPPRESSIVE MEDICINES, Dialysis & transplantation, 23(10), 1994, pp. 571-574
Risultati: 1-10 |